SCHEMBL30408552

SCHEMBL30408552

C/C(=C\c1ccc(-c2nc(Cc3cccc(Cl)c3)no2)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HTT P42858 2/20 0.53
ERCC1 P07992 1/20 0.43
ERCC4 Q92889 1/20 0.43
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HDAC6 Q9UBN7 1/20 0.43
DGAT1 O75907 1/20 0.42
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TBXAS1 P24557 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NOTUM Q6P988 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26134387 1.00 NPC1 (0.53) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26425968 0.88 HTT (0.48) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL30408238 0.88 HTT (0.48) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL31024154 0.83 NPC1 (0.55) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26087633 0.83 NPC1 (0.55) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26425656 0.79 NPC1 (0.54) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26090397 0.79 NPC1 (0.63) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26425647 0.79 NPC1 (0.63) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL30407330 0.79 NPC1 (0.47) NPC1RAB9AHTTERCC1ERCC4
SCHEMBL26090394 0.78 NPC1 (0.53) NPC1RAB9AHTTERCC1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425513-A1 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. 2024-12-26 US disclosed
EP-4419508-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 Carmot Therapeutics, Inc. (US) 2024-08-28 EP disclosed
WO-2023069721-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425513-A1 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 USP28, USP25, USP39 NPC1 3849/4885RAB9A 3643/4885HTT 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.